Evidence map›Paper›PMID 38347087›Full record

ArticleScientific reports2024

Microbial butyrate capacity is reduced in inflamed mucosa in patients with ulcerative colitis.

Sushrut Jangi, John Moyer, Sarah Sandlow, May Fu, Hannah Chen, Ann Shum, Katie Hsia, Laura Cersosimo, Vladimir Yeliseyev, Naisi Zhao and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Fecal microbial transplants as investigative tools in cancer.American journal of physiology. Gastrointestinal and liver physiology · 2024
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Sushrut JangiDepartment of Medicine, Tufts Medical Center, Boston, MA, USA. sjangi@tuftsmedicalcenter.org.
John MoyerDepartment of Medicine, Tufts Medical Center, Boston, MA, USA.
Sarah SandlowDepartment of Medicine, Tufts Medical Center, Boston, MA, USA.
May FuPathology and Laboratory Medicine, Tufts Medical Center, Boston, MA, USA.
Hannah ChenPathology and Laboratory Medicine, Tufts Medical Center, Boston, MA, USA.
Ann ShumDepartment of Medicine, Tufts Medical Center, Boston, MA, USA.
Katie HsiaDepartment of Medicine, Tufts Medical Center, Boston, MA, USA.
Laura CersosimoDepartment of Pathology, Brigham and Women's Hospital, 221 Longwood Ave, Boston, MA, USA.
Vladimir YeliseyevDepartment of Pathology, Brigham and Women's Hospital, 221 Longwood Ave, Boston, MA, USA.
Naisi ZhaoPublic Health and Community Medicine, Tufts University School of Medicine, Boston, Ma, USA.
Lynn BryDepartment of Pathology, Brigham and Women's Hospital, 221 Longwood Ave, Boston, MA, USA.
Dominique S MichaudPublic Health and Community Medicine, Tufts University School of Medicine, Boston, Ma, USA.
Tufts Medical Center · USBrigham and Women's Hospital · USTufts University · US

Funding

CTSA K12 Program at Tufts UniversityK12TR004384 · NCATS · TUFTS UNIVERSITY BOSTON · PI Karen Freund, Lesley Ann Inker · 2023 to 2026
$6.1M
NCATS NIH HHS K12 TR004384NCATS NIH HHS K12TR004384
6 · The paper itself

Abstract

Reduced butyrate-production capacity has been reported in fecal microbial communities in patients with active ulcerative colitis. However, the butyrate-production capacity of the mucosal microbiome from active vs quiescent mucosa in ulcerative colitis has been unexplored. We sought to determine the diversity and relative abundance of mucosal bacterial and fungal communities from endoscopically active vs quiescent mucosa in patients with UC, and aimed to predict contributions of mucosal microbial communities to butyrate synthesis. Systematic, segmental right- and left-sided biopsies were obtained from endoscopically active (n = 13) or quiescent (n = 17) colonic mucosa, among 15 patients with pan-colonic ulcerative colitis. Dietary fiber intake of patients was performed using the validated five-item FiberScreen questionnaire. Amplicon sequencing of mucosal bacteria and fungi was performed. The diversity and relative abundance of mucosal bacterial and fungal taxa were quantified, and predicted contributions to butyrate synthesis were ascertained. Bacterial alpha and beta diversity were similar between active vs quiescent mucosa. Butyrogenic taxa were significantly increased in quiescence, including Butyricimonas, Subdoligranulum, and Alistipes. Predicted butyrate kinase activity was significantly and concomitantly increased in quiescent mucosa. Fiber intake was positively correlated with butyrogenic microbes. Compared to mucosal bacterial prevalence, mucosal fungi were detected in low prevalence. Butyrogenic microbes are relatively increased in quiescent mucosa in ulcerative colitis, and may be related to increased fiber intake during quiescence. Manipulation of the mucosal microbiome towards butyrate-producing bacteria may be associated with endoscopic quiescence.

Indexed as

Colitis, UlcerativeBacteriaBiopsyButyratesColonHumansIntestinal MucosaButyratesInflammatory bowel diseaseMucosal mycobiomeShort chain fatty acids

Identifiers

PMID38347087
PMCPMC10861456
OpenAlexW4391738691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.